cAMP induces ABCA1 phosphorylation activity and promotes cholesterol efflux from fibroblasts

Journal of Lipid Research

Volumn 43, Issue 12, 2002, Pages 2087-2094

  Haidar, Bassam ^a,b   Denis, Maxime ^a,b   Krimbou, Larbi ^a   Marcil, Michel ^a   Genest, Jacques ^a  

^a ROYAL VICTORIA HOSPITAL   (Canada)

^b UNIVERSITY OF MONTREAL   (Canada)

Author keywords

Apolipoprotein A 1; High density lipoprotein; PKA; Protein kinase A

Indexed keywords

8 BROMO CYCLIC AMP; ABC TRANSPORTER; APOLIPOPROTEIN A1; CHOLESTEROL; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITOR; CYCLODEXTRIN; FORSKOLIN; MUTANT PROTEIN; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; ABC TRANSPORTER A1; MESSENGER RNA;

ARTICLE; CHEMICAL BINDING; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; DOSE RESPONSE; FIBROBLAST; GENE MUTATION; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TANGIER DISEASE; TIME; BIOSYNTHESIS; DRUG ANTAGONISM; GENETICS; METABOLISM; MUTATION; PHOSPHORYLATION; PHYSIOLOGY;

APOLIPOPROTEIN A-I; ATP-BINDING CASSETTE TRANSPORTERS; CHOLESTEROL; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; FIBROBLASTS; HUMANS; MUTATION; PHOSPHORYLATION; RNA, MESSENGER; SIGNAL TRANSDUCTION; TANGIER DISEASE;

EID: 0036906470     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: 10.1194/jlr.M200235-JLR200     Document Type: Article

References (33)

1. Brooks-Wilson, A., M. Marcil, S. M. Clee, I. H. Zhang, K. Roomp, M. van Dam, L. Yu, C. Brewer, J. A. Collins, H. O. Molhuizen, O. Loubser, B. F. Ouelette, K. Fichter, K. J. Ashbourne-Excoffon, C. W. Sensen, S. Scherer, S. Mott, M. Denis, D. Martindale, J. Frohlich, K. Morgan, B. Koop, S. Pimstone, J. J. Kastelein, J. Genest Jr., M. R. Hayden. 1999. Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency. Nat. Genet. 22:336-345.
2. Marcil, M., A. Brooks-Wilson, S. M. Clee, K. Roomp, L. H. Zhang, L. Yu, J. A. Collins, M. van Dam, H. O. Molhuizen, O. Loubster, B. F. Ouellette, C. W. Sensen, K. Fichter, S. Mott, M. Denis, B. Boucher, S. Pimstone, J. Genest, Jr., J. J. Kastelein, M. R. Hayden. 1990. Mutations in the ABC1 gene in familial HDL deficiency with defective cholesterol efflux. Lancet. 354: 1541-1546.
3. Batal, R., M. Tremblay, L. Krimbou, O. Mamer, J. Davignon, J. Genest, Jr., and J. S. Cohn. 1998. Familial HDL deficiency characterized by hypercatabolism of mature apoA-I but not proapoA-I. Arterioscler. Thromb. Vasc. Biol. 18: 655-664.
4. Tall, A. R. 1993. Plasma cholesteryl ester transfer protein. J. Lipid Res. 34: 1255-1274.
5. Croop, J. M. 1998. Evolutionary relationships among ABC transporters. Methods Enzymol. 292: 101-116.
6. Tusnady, G. E., E. Bakos, A. Varadi, and B. Sarkadi. 1997. Membrane topology distinguishes a subfamily of the ATP-binding cassette (ABC) transporters. FEBS Lett. 402: 1-3.
7. Thomas, P. M., G. J. Cote, N. Wohllk, B. Haddad, P. M. Mathew, W. Rabl, L. Aguilar-Bryan, R. F. Gagel, and J. Bryan. 1995. Mutations in the sulfonylurea receptor gene in familial persistent hyprinsulinemic hypoglycemia of infancy. Science. 269: 426-429.
8. Strautnieks, S. S., L. N. Bull, A. S. Knisely, S. A. Kocoshis, N. Dahl, H. Arnell, E. Sokal, K. Dahan, S. Childs, V. Ling, M. S. Tanner, A. F. Kagalwalla, A. Nemeth, J. Pawlowska, A. Baker, G. Meili-Vergani, N. B. Freimer, R. M. Gardiner, R. J. Thompson. 1998. A gene encoding a liver-specific ABC transporter is mutated in progressive familial intrahepatic cholestasis. Nat. Genet. 20:233-238
9. Demolombe, S., and D. Escande. 1996. ATP-binding cassette proteins as targets for drug discovery. Trends Pharmacol. Sci. 17:273-275.
10. Dean, M., and R. Allikmets. 1995. Evolution of ATP-binding cassette transporter genes. Curr. Opin. Genet. Dev. 5: 779-785.
11. Walker, J. E., M. Saraste, M. J. Runswick, and N. J. Gay. 1982. Distantly related sequences in the alpha- and beta-subunits of ATP synthase, myosin, kinases and other ATP-requiring enzymes and a common nucleotide binding fold. EMBO J. 1: 945-951.
12. Saraste, M., P. R. Sibbald, and A. Wittinghofer. 1995. The P-loopa common motif in ATP- and GTP-binding proteins. Trends Biochem. Sci. 15: 430-434.
13. Picciotto, M. R., J. A. Cohn, G. Bertuzzi, P. Greengard, and A. C. Nairn. 1992. Phosphorylation of the cystic fibrosis transmembrane conductance regulator. J. Biol. Chem. 267: 12742-12752.
14. Smith, J. D., M. Miyata, M. Ginsberg, C. Grigaux, E. Shmookler, and A. S. Plump. 1996. Cyclic AMP induces apolipoprotein E binding activity and promotes cholesterol efflux from a macrophage cell line to apolipoprotein acceptors. J. Biol. Chem. 271: 30647-30655.
15. Takahashi, Y., and J. D. Smith. 1999. Cholesterol efflux to apolipoprotein A1 involves endocytosis and resecretion in a calcium-dependent pathway. Proc. Natl. Acad. Sci. USA. 95: 11353-11363.
16. Bortnick, A. E., G. H. Rothblat, G. Stoudt, K. L. Hoppe, L. J. Royer, J. McNeish, and O. L. Francone. 2000. The correlation of ATP-binding cassette 1 mRNA levels with cholesterol efflux from various cell lines. J. Biol. Chem. 275: 28634-28640.
17. Oram, J. F., R. M. Lawn, M. R. Garvin, and D. P. Wade. 2000. ABCA1 is the cAMP-inducible apolipoprotein receptor that mediates cholesterol secretion from macrophages. J. Biol. Chem. 275: 34508-34511.
18. Lawn, R. M., D. P. Wade, M. R. Garvin, X. Wang, K. Schwartz, J. G. Porter, J. J. Seilhamer, A. M. Vaughan, and J. P. Oram. 1999. The Tangier disease gene product ABC1 controls the cellular apolipoprotein-mediated lipid removal pathway. J. Clin. Invest. 104: R25-R31.
19. Oram, J. F., A. J. Mendez, J. Lymp, T. J. Kavanagh, and C. L. Halbert. 1999. Reduction in apolipoprotein-mediated removal of cellular lipids by immortalization of human fibroblasts and its reversion by cAMP: Lack of effect with Tangier disease cells. J. Lipid Res. 40: 1769-1781.
20. Haidar, B., S. Mott, B. Boucher, C. Y. Lee, M. Marcil, and J. Genest, Jr. 2001. Cellular cholesterol efflux is modulated by phospholipid-derived signaling molecules in familial HDL deficiency/Tangier disease fibroblasts. J Lipid Res. 42: 249-257.
21. Marcil, M., L. Yu, L. Krimbou, B. Boucher, J. F. Oram, J. S. Cohn, and J. Genest, Jr. 1999. Cellular cholesterol transport and efflux in fibroblasts are abnormal in subjects with familial HDL deficiency. Arterioscler. Thromb. Vasc. Biol. 19: 159-169.
22. Marcil, M., B. Boucher, L. Krimbou, B. C. Solymoss, J. Davignon, J. Frohlich, J. Genest, Jr. 1995. Severe familial HDL deficiency in French-Canadian kindreds. Clinical, biochemical, and molecular characterization. Arterioscler. Thromb. Vasc. Biol. 15: 1015-1024.
23. Lowry, O., N. J. Rosebrogh, A. L. Farr, and R. J. Randall. 1951. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193: 265-275.
24. Bernard, D. W., A. Rodriguez, G. H. Rothblat, and J. M. Glick. 1991. cAMP stimulates cholesteryl ester clearance to high density lipoproteins in J7774 macrophages. J. Biol. Chem. 266: 710-716.
25. Laffont, I., M. Takahashi, Y. Shibukawa, K. Honke, V. V. Shuvaev, G. Siest, S. Visvikis, and N. Taniguchi. 2002. Apolipoprotein E activates Akt pathway in neuro-2a in an isoform-specific manner. Biochem. Biophys. Res. Commun. 292: 83-87.
26. Kanda, Y., R. G. Richards, and S. Handwerger. 1998. Apolipoprotein A-I stimulates human placental lactogen release by activation of MAP kinase. Mol. Cell. Endocrinol. 143: 125-131.
27. Tang, W. J., and A. G. Gilman. 1992. Adenylyl cyclases. Cell. 70:. 869-872.
28. Wang, N., D. L. Silver, P. Costet, and A. R. Tall. 2000. Specific binding of ApoA-1, enhanced cholesterol efflux, and altered plasma membrane morphology in cells expressing ABC1. J. Biol. Chem. 275: 33053-33058.
29. Francis, G. A., R. H. Knopp, and J. F. Oram. 1998. Defective removal of cellular cholesterol and phospholipids by apolipoprotein A-I in Tangier Disease. J. Chin. Invest. 96: 78-87.
30. Ito, K., C.J. Oleschuk, C. Westlake, M. Z. Vasa, R. G. Deeley, and S. P. Cole. 2001. Mutation of TrpI254 in the multispecific organic anion transporter, multidrug resistance protein 2 (MRP2) (ABCC2), alters substrate specificity and results in loss of methotrexate transport activity. J. Biol. Chem. 276: 38108-38114.
31. Berger, H. A., S. M. Travis, and M. J. Welsh. 1993. Regulation of the cystic fibrosis transmembrane, conductance regulator CI-channel by specific protein kinases and protein phosphatases. J. Biol. Chem. 268: 2037-2047.
32. Fitzgerald, M. L., A. L. Morris, J. S. Rhee, L. P. Andersson, A. J. Mendez, and M. W. Freeman. 2002. Naturally occurring mutations in ABCA1's largest extracellular loops can disrupt its direct interaction with apolipoprotein A-I. J. Biol. Chem. In press.
33. Clee, S. M., J. J. Kestelein, M. van Dam, M. Marcil, K. Roomp, K. Y. Zwarts, J. A. Collins, R. Roelants, N. Tamasawa, T. Stulc, T. Suda, R. Ceska, B. Boucher, C. Rondeau, C. DeSouich, A. Brooks-Wilson, H. O. Molhuizen, J. Frohlich, J. Genest, Jr., M. R. Hayden. 2000. Age and residual cholesterol efflux affect HDL cholesterol levels and coronary, artery, disease in ABCA1 heterozygotes. J. Clin. Invest. 106: 1263-1270.